| MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion N Xu, L Zhang, F Meisgen, M Harada, J Heilborn, B Homey, D Grandér, ... Journal of Biological Chemistry 287 (35), 29899-29908, 2012 | 207 | 2012 |
| DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1 M Lerner, M Harada, J Lovén, J Castro, Z Davis, D Oscier, M Henriksson, ... Experimental cell research 315 (17), 2941-2952, 2009 | 195 | 2009 |
| A comprehensive review of cancer MicroRNA therapeutic delivery strategies A Forterre, H Komuro, S Aminova, M Harada Cancers 12 (7), 1852, 2020 | 170 | 2020 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 125 | 2024 |
| MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma E Sonkoly, J Lovén, N Xu, F Meisgen, T Wei, P Brodin, V Jaks, M Kasper, ... Oncogenesis 1 (3), e3-e3, 2012 | 119 | 2012 |
| Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia M Harada, K Pokrovskaja-Tamm, S Söderhäll, M Heyman, D Grander, ... Leukemia & lymphoma 53 (10), 2041-2050, 2012 | 62 | 2012 |
| MicroRNA-203 inversely correlates with differentiation grade, targets c-MYC, and functions as a tumor suppressor in cSCC W Lohcharoenkal, M Harada, J Lovén, F Meisgen, NX Landén, L Zhang, ... Journal of Investigative Dermatology 136 (12), 2485-2494, 2016 | 47 | 2016 |
| Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells E Buentke, A Nordström, H Lin, AC Björklund, E Laane, M Harada, L Lu, ... Blood Cancer Journal 1 (7), e31-e31, 2011 | 45 | 2011 |
| The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression M Harada, J Benito, S Yamamoto, S Kaur, D Arslan, S Ramirez, R Jacamo, ... Oncotarget 6 (35), 37930, 2015 | 43 | 2015 |
| MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors M Lerner, M Haneklaus, M Harada, D Grander PloS one 7 (5), e36490, 2012 | 33 | 2012 |
| Nano-immunoimaging P Wang, T Kim, M Harada, C Contag, X Huang, BR Smith Nanoscale horizons 5 (4), 628-653, 2020 | 23 | 2020 |
| Engineering extracellular vesicles to target pancreatic tissue in vivo H Komuro, Y Kawai-Harada, S Aminova, N Pascual, A Malik, CH Contag, ... Nanotheranostics 5 (4), 378, 2021 | 19 | 2021 |
| Advances of engineered extracellular vesicles-based therapeutics strategy H Komuro, S Aminova, K Lauro, M Harada Science and Technology of Advanced Materials 23 (1), 655-681, 2022 | 14 | 2022 |
| DesigN and evaluation of engineered extracellular vesicle (EV)-based targeting for EGFR-overexpressing tumor cells using monobody display H Komuro, S Aminova, K Lauro, D Woldring, M Harada Bioengineering 9 (2), 56, 2022 | 11 | 2022 |
| Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery AH Mohammadi, Z Ghazvinian, F Bagheri, M Harada, K Baghaei BioDrugs 37 (3), 353-374, 2023 | 6 | 2023 |
| Selective inhibitor of nuclear export selinexor (KPT-330) and BCL2 inhibitor ABT-199 enhance the anti-lymphoma effect of BTK inhibitor ibrutinib in mantle cell lymphoma Y Tabe, M Harada, Y Miyamae, S Kazuno, T Fujimura, T Ueno, T Miida, ... Blood 124 (21), 2254, 2014 | 6 | 2014 |
| Evaluation of EV Storage Buffer for Efficient Preservation of Engineered Extracellular Vesicles Y Kawai-Harada, H El Itawi, H Komuro, M Harada International Journal of Molecular Sciences 24 (16), 12841, 2023 | 2 | 2023 |
| MiR-203 suppresses cutaneous squamous cell carcinoma growth and targets the myc oncogene W Lohcharoenkal, M Harada, J Lovén, F Meisgen, NX Landén, L Zhang, ... Cancer Research 76 (14_Supplement), 1098-1098, 2016 | 1 | 2016 |
| Bone Marrow Adipocyte-Derived Free Fatty Acids Induce Gene Signature Linking Transcription with Metabolic Changes That Contribute to Survival of Acute Monocytic Leukemia Cells Y Tabe, M Harada, Y Miyamae, K Mogushi, S Kazuno, T Fujimura, ... Blood, The Journal of the American Society of Hematology 124 (21), 1013-1013, 2014 | 1 | 2014 |
| The mTOR Kinase Inhibitor AZD-2014 Effectively Reverses XPO1/CRM1 Antagonist KPT-185–induced Glycolysis/Gluconeogenesis, Enhancing Antitumor Effects in Mantle Cell Lymphoma Y Tabe, M Harada, Y Miyamae, H Matsushita, K Kojima, T Fujimura, ... Blood 124 (21), 925, 2014 | 1 | 2014 |
Ning Xu LandénKarolinska InstitutetVerified email at ki.se
